Thermo Fisher Scientific Commits to Achieve Net-Zero Carbon Emissions by 2050

- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced its commitment to achieve net-zero carbon emissions by 2050. This supports the global goals of the Paris Climate Agreement and the United Nations' Race To Zero campaign and will further advance the company's current strategy to mitigate its impact on the environment.

Thermo Fisher's carbon reduction efforts build on its 2030 targets to reduce greenhouse gas (GHG) emissions across its operations (Scopes 1 and 2). Established in 2019, these goals are aligned with the criteria of the Science Based Targets initiative (SBTi). Thermo Fisher's new pledge to reach carbon neutrality by 2050 incorporates additional targets to reduce its value chain emissions (Scope 3), including a commitment to SBTi's most ambitious guidelines.

"To better serve our customers and society overall, we continue to build on our commitment to sustainability," said Marc N. Casper , chairman, president and chief executive officer, Thermo Fisher Scientific. "At Thermo Fisher, we have a culture of continuous improvement, which is powered by our PPI Business System. Our goal to find a better way every day inspires our colleagues to drive innovation and deliver new solutions. The effort to achieve net-zero emissions by 2050 will further engage all 80,000 of our colleagues to address climate change."

Meeting a net-zero commitment for the future requires innovating today. Thermo Fisher is moving forward on this front by making its facilities more energy efficient, increasing the use of renewable energy and reducing waste in its operations. The company also plays a critical role in advancing climate science as a whole. Its leading analytical instruments spur the creation of green technologies and allow researchers to further investigate global warming. All of these efforts will help enable customers and partners to achieve their climate goals.

Casper continued, "Our goal to achieve carbon neutrality is another example of our commitment to doing business the right way and our mission to enable our customers to make the world healthier, cleaner and safer. We are taking deliberate actions today to strengthen our business for tomorrow's customers, colleagues and communities."

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com .

Media Contact Information:
Ron O'Brien
Thermo Fisher Scientific
Phone: 781-622-1242
E-mail: ron.obrien@thermofisher.com

Investor Contact Information:
Rafael Tejada
Thermo Fisher Scientific
Phone:  781-622-1356
E-mail: rafael.tejada@thermofisher.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/thermo-fisher-scientific-commits-to-achieve-net-zero-carbon-emissions-by-2050-301341490.html

SOURCE Thermo Fisher Scientific

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at... Keep Reading...
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the... Keep Reading...
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries CommenceDownload the PDF here. Keep Reading...

Latest Press Releases

Related News